Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/2010
09/23/2010US20100239692 Methods of treatment for hemolysis
09/23/2010US20100239592 Methods of analysis and detecting molecular defects in transcobalamin i deficiency
09/23/2010US20100239583 Antibodies against flagellin and uses thereof
09/23/2010US20100239554 Extended recombinant polypeptides and compositions comprising same
09/23/2010US20100239539 Methods for promoting differentiation and differentiation efficiency
09/23/2010CA2755726A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/23/2010CA2755697A1 Amide derivative
09/23/2010CA2755569A1 Transdermal pharmaceutical preparation and administration of tirofiban
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2230252A1 Augmentation of endothelial thromboresistance
09/22/2010EP2229392A1 Triazolotriazines and triazolopyrazines and their use as gsk3beta inhibitors
09/22/2010EP2229173A1 Oxazolidinones for the treatment and/or prophylaxis of heart failure
09/22/2010EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
09/22/2010EP1401853B1 Modulators of pharmacological agents
09/22/2010EP1371663B1 Anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process
09/22/2010EP1335938B1 Apolipoprotein construct
09/22/2010CN1612746B Use of HEPCIDIN as a regulator of iron homeostasis
09/22/2010CN101842093A PAI-1 production inhibitor
09/22/2010CN101838323A Anti-platelet thrombolysin and preparation method thereof
09/22/2010CN101838308A Solid-phase synthesis method for eptifibatide
09/22/2010CN101838277A Cefotetan disodium hydrate and preparation method and application thereof
09/22/2010CN101838202A Total terpenoids of ferula dissecta as well as medical application and preparation method thereof
09/22/2010CN101837144A American-cockroach-extract-containing gelatin sponge and preparation method thereof
09/22/2010CN101837119A Method for preparing interleukin-11 semi-finished product solution, and products thereof
09/22/2010CN101837097A Method for manufacturing specific hemostatic powder
09/22/2010CN101837069A Method for preparing eggplant wine
09/22/2010CN101837059A Method for preparing apple polyphenol
09/22/2010CN101837048A Chinese medicament for curing metrorrhagia or pregnant bleeding of women
09/22/2010CN101837028A Selaginella uncinata extract dripping pill and preparation method thereof
09/22/2010CN101837018A American cockroach medicinal composition for curing ulcers or ulcerative inflammation and preparation method thereof
09/22/2010CN101837015A Peritoneal dialysis medicinal composition with effect of improving side effects
09/22/2010CN101837010A Preparation process of non-PVC soft-bag packing peritoneal dialysis solution and product thereof
09/22/2010CN101836998A Application of tyrosol glucoside in preparing anti-hemorrhagic shock drug
09/22/2010CN101836997A Glycerol/fructose composite and preparation method thereof
09/22/2010CN101836978A Solid preparation containing single crystal form
09/22/2010CN101836972A Novel purposes of ferulic acid
09/22/2010CN101234094B Dipyridamole orally disintegrating tablet
09/22/2010CN101224273B Preparing method of Jiaozhi soft capsule
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799773 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans
09/21/2010US7799762 Functionally substituted amino acids, having fatty acid chains bound through amidification of the amine functional groups of dipeptide like compounds, one end bears a functional side chain and other side neutral or charged acid
09/21/2010US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
09/21/2010CA2438593C Glucopyranosyloxypyrazole derivatives and medicinal use thereof
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2396045C Aqueous ionic solutions and their uses in particular in ophthalmology
09/21/2010CA2367457C Protein for blocking platelet adhesion
09/21/2010CA2307142C N-terminally chemically modified protein compositions and methods
09/21/2010CA2306692C Dipeptide apoptosis inhibitors and the use thereof
09/21/2010CA2234941C Delivery of biologically active polypeptides
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010103475A2 Use of serine protease inhibitors in the treatment of neutropenia
09/16/2010WO2010056981A3 Methods and compositions for regulating iron homeostasis by modulation bmp-6
09/16/2010US20100234578 Anti-cd40 monoclonal antibody
09/16/2010US20100234448 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100234380 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
09/16/2010US20100234352 Factor xa inhibitors
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
09/16/2010US20100234317 Use of difructose anhydride-containing composition
09/16/2010US20100234309 Dendrimer Compositions
09/16/2010US20100234291 Preparation and use of low-bleeding anticoagulant fusion protein
09/16/2010US20100234290 Stabilized Insulin-like Growth Factor Polypeptides
09/16/2010US20100233810 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100233735 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
09/16/2010US20100233290 Use of difructose anhydride-containing composition
09/16/2010US20100233253 Extended release gastro-retentive oral drug delivery system for valsartan
09/16/2010US20100233248 Clay-based hemostatic agents and devices for the delivery thereof
09/16/2010US20100233236 Drug coated expandable devices
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/16/2010US20100233168 Rationale for IL-1 Beta targeted therapy in sickle cell disease for ischemia-reperfusion induced complications
09/16/2010US20100233149 Methods for preparing Factor X, activated Factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
09/16/2010US20100233144 Method for optimizing blood cell transplants
09/16/2010US20100233119 Suppression of immune response to factor viii in hemophilia a patients
09/16/2010US20100233083 Microparticles comprising a crosslinked polymer
09/16/2010US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof
09/16/2010CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010CA2753282A1 Use of serine protease inhibitors in the treatment of neutropenia
09/15/2010EP2228448A1 MU-1 member of the cytokine receptor family
09/15/2010EP2228435A1 Method for amplification of hematopoietic stem cell using heterocyclic compound
09/15/2010EP2228434A1 Amplification method for hematopoietic stem cells with heterocyclic compound
09/15/2010EP2228378A1 Monosebacate of pyrazole derivative
09/15/2010EP2227475A1 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions
09/15/2010EP2227466A2 Heteroaryl-substituted piperidines
09/15/2010EP2227222A2 Resuscitation fluid
09/15/2010EP1845951B1 Embolization using poly-4-hydroxybutyrate particles
09/15/2010EP1501819B1 Estrogen receptor modulators
09/15/2010EP1430140B1 N-terminally truncated isoforms of pde3a cyclic phosphodiesterases
09/15/2010EP1351681B1 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
09/15/2010CN101831433A Zebra fish P-selectin gene, encoded protein and application thereof
09/15/2010CN101830957A Process for preparing ginsenosides Rh2 and Rh3 from stems and leaves of pseudoginseng root
09/15/2010CN101830916A Cefbuperazone sodium hydrate, preparation method thereof and application thereof
09/15/2010CN101830911A Thienopyridine derivatives, preparation method and application thereof
09/15/2010CN101829325A Pharmaceutical composition for treatment of diseases caused by IL-6 production
09/15/2010CN101829317A Application of delta opiate receptor antagonist ICI174, 864 for preparing haemorrhagic shock resisting medicine
09/15/2010CN101829300A Hyperthermia agent with high thermal efficiency and multiple functions
1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 671